Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11534430
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
granted -
US 11529395
Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
granted -
US 11524053
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
granted -
US 11524013
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
granted -
US 11517564
Methods of treatment for cystic fibrosis
granted -
US 11512309
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11512141
Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment
granted -
US 11510887
Sobetirome in the treatment of myelination diseases
granted -
US 11512052
Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
granted -
US 11512312
Treatment of Fuchs' endothelial corneal dystrophy
granted -
US 11505604
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 11505572
Therapeutics for the treatment of glaucoma
granted -
US 11504390
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
granted -
US 11505574
Modulation of P53 for the treatment of cancer
granted -
US 11497739
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with a-beta peptide aggregation
granted -
US 11497725
Treatment for obesity
granted -
US 11497740
Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
granted -
US 11497736
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted -
US 11491212
Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B
granted -
US 11492643
Methods and compositions for treatment of a genetic condition
granted -
US 11484523
Compositions for prevention and treatment of symptoms associated with alcohol consumption
granted -
US 11484511
Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer
granted -
US 11478571
Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury
granted -
US 11479530
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
granted